Nektar Therapeutics develops therapies focused on immune-mediated diseases and inflammatory conditions. The company engages in scientific research, therapeutic discovery, clinical development, and commercialization, often in collaboration with pharmaceutical partners. Nektar's expertise lies in immune system modulation, targeting the root causes of immune dysfunction to create treatments that aim to improve patient outcomes.
